Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Randomized Open Label Study of Neo-Adjuvant Degarelix vs. LHRH Agonist in Prostate Cancer Patients Prior to Radical Prostatectomy

NCT01674270 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT01674270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01674270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Randomized Open Label Study of Neo-Adjuvant Degarelix vs. LHRH Agonist in Prostate Cancer Patients Prior to Radical Prostatectomy
Lead sponsor
University Health Network, Toronto
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2012
Completion date
November 30, 2015
Enrollment
35 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer